BCX9930 for the Treatment of PNH in Subjects Not Receiving Other Complement Inhibitor Therapy
Status:
Recruiting
Trial end date:
2023-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of BCX9930 monotherapy for
the treatment of adult patients with PNH not currently receiving complement inhibitor
therapy.